Credit Suisse analyst A.J. Rice lowered the firm’s price target on Centene to $87 from $94 and keeps an Outperform rating on the shares following quarterly results. For 2024, Centene rebased its adjusted EPS to at least $6.60 from a floor of $7.15, previously, reflecting updated views on Medicaid redeterminations, its 2024 MA bid strategy, and high-impact investments in the business, the firm notes.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on CNC:
- Centene price target lowered to $86 from $90 at Barclays
- Early notable gainers among liquid option names on April 25th
- Centene raises FY23 adjusted EPS view to at least $6.40 from $6.25-$6.40
- Centene reports Q1 adjusted EPS $2.11, consensus $2.10
- CENTENE CORPORATION REPORTS FIRST QUARTER 2023 RESULTS
Questions or Comments about the article? Write to editor@tipranks.com